Detected ·
SonoThera
$125M—
SonoThera raised $125M in Series B led by Vida Ventures, with participation from Leaps by Bayer, Otsuka Pharmaceutical, UCB Ventures, and Johnson & Johnson Innovation – JJDC. The company uses ultrasound and microbubbles to deliver genetic medicines non-virally, targeting DMD and polycystic kidney disease with a first-in-human trial planned for 2027.
- Website
- sonothera.com
- linkedin.com/company/sonothera
- Amount
- $125 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-25 08:07:24 UTC
- Signal ID
- 02f9991e-6208-43f5-90d0-634f3f75e494
As the API returns it
{
"id": "02f9991e-6208-43f5-90d0-634f3f75e494",
"created_at": "2026-06-25T08:07:24.186646Z",
"company_name": "SonoThera",
"company_website_url": "sonothera.com",
"company_linkedin_url": "https://www.linkedin.com/company/sonothera",
"event_type": "funding",
"funding_amount": 125000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*SonoThera raised $125M in Series B led by Vida Ventures, with participation from Leaps by Bayer, Otsuka Pharmaceutical, UCB Ventures, and Johnson & Johnson Innovation – JJDC. The company uses ultrasound and microbubbles to deliver genetic medicines non-virally, targeting DMD and polycystic kidney disease with a first-in-human trial planned for 2027.*"
}